Sherie A. Dowsett
ORCID: 0009-0000-6388-0250
· 2 papers in corpus
article
2011
OBJECTIVE: The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene. METHODS: A predefined objective of the trial was to …
article
2002